Tumour heterogeneity and the impact on patient care
14 Sep 2016
Tumour heterogeneity and the impact on patient care
Developing new models in SCLC
Future of imaging in lung cancer
Understanding the mechanisms of immunotherapy in lung cancer
Nitroglycerin in cancer treatment
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
State of the art imaging and lung cancer management
Future smart surgical approaches for brain metastases
Future directions in radiation medicine
How to avoid false positives in lung cancer
Current state of the art radiotherapy in lung cancer
Maintenance in NSCLC